Danos Olivier

CIK 00017011801 companyROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001701180

Recent Transactions

37 trades

Award
REGENXBIO Inc.$RGNX
Common Stock
2024-08-01+58,867→ 185,083 total
Award
REGENXBIO Inc.$RGNX
Common Stock
2024-06-28$9.95/sh+1,363→ 126,216 total
Award
REGENXBIO Inc.$RGNX
Stock Options (Right to buy)
2024-01-02+61,050→ 61,050 total
Award
REGENXBIO Inc.$RGNX
Common Stock
2024-01-02+38,462→ 124,853 total
Tax Payment
REGENXBIO Inc.$RGNX
Common Stock
2024-01-02$17.95/sh−8,410→ 86,391 total
Award
REGENXBIO Inc.$RGNX
Common Stock
2023-06-30$16.99/sh+1,123→ 94,801 total
Award
REGENXBIO Inc.$RGNX
Stock Options (Right to buy)
2023-01-03+52,986→ 52,986 total
Tax Payment
REGENXBIO Inc.$RGNX
Common Stock
2023-01-03$22.68/sh−2,058→ 27,020 total
Award
REGENXBIO Inc.$RGNX
Common Stock
2023-01-03+65,930→ 92,950 total
Award
REGENXBIO Inc.$RGNX
Common Stock
2022-06-30$21.00/sh+728→ 93,678 total
Award
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2022-01-03+51,100→ 51,100 total
Award
REGENXBIO Inc.$RGNX
Common Stock
2022-01-03+10,700→ 29,078 total
Tax Payment
REGENXBIO Inc.$RGNX
Common Stock
2022-01-01$32.70/sh−1,221→ 18,378 total
Award
REGENXBIO Inc.$RGNX
Common Stock
2021-12-31$27.80/sh+1→ 19,599 total
Award
REGENXBIO Inc.$RGNX
Common Stock
2021-06-30$33.02/sh+555→ 19,598 total
Award
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2021-01-04+52,500→ 52,500 total
Award
REGENXBIO Inc.$RGNX
Common Stock
2021-01-04+11,600→ 19,043 total
Award
REGENXBIO Inc.$RGNX
Common Stock
2020-06-30$31.31/sh+641→ 7,443 total
Award
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2020-01-02+48,000→ 48,000 total
Award
REGENXBIO Inc.$RGNX
Common Stock
2019-12-31$34.82/sh+302→ 6,802 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2019-04-15−2,000→ 71,500 total
Sale
REGENXBIO Inc.$RGNX
Common Stock
2019-04-15$53.09/sh−1,000→ 6,500 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Common Stock
2019-04-15$20.35/sh+2,000→ 8,500 total
Sale
REGENXBIO Inc.$RGNX
Common Stock
2019-04-15$52.23/sh−1,000→ 7,500 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2019-03-12−5,000→ 73,500 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Common Stock
2019-03-12$20.35/sh+5,000→ 6,500 total
Award
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2019-01-03+48,000→ 48,000 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2018-11-30−1,500→ 78,500 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Common Stock
2018-11-30$20.35/sh+1,500→ 1,500 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Common Stock
2018-10-08$20.35/sh+20,000→ 20,000 total
Sale
REGENXBIO Inc.$RGNX
Common Stock
2018-10-08$64.78/sh−4,000→ 216 total
Sale
REGENXBIO Inc.$RGNX
Common Stock
2018-10-08$65.60/sh−216→ 0 total
Sale
REGENXBIO Inc.$RGNX
Common Stock
2018-10-08$62.79/sh−3,500→ 16,500 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2018-10-08−20,000→ 80,000 total
Sale
REGENXBIO Inc.$RGNX
Common Stock
2018-10-08$63.73/sh−12,284→ 4,216 total
Award
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2018-01-03+41,250→ 41,250 total
Award
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2017-03-27+100,000→ 100,000 total

Companies

REGENXBIO Inc.
Chief Scientific Officer
$RGNX

Recent Filings

Address

C/O REGENXBIO INC. 9600 BLACKWELL ROAD, SUITE 210

ROCKVILLE, MD, 20850

View on SEC.gov